| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/14/1993 | EP0536350A1 Identification of a novel human receptor tyrosine kinase gene |
| 04/14/1993 | EP0536335A1 Compositions and methods for the prevention and diagnosis of lyme disease |
| 04/14/1993 | EP0536322A1 HUMAN MACROPHAGE INFLAMMATORY PROTEIN 2$g(a) |
| 04/14/1993 | EP0536319A1 Assay for detecting and/or quantifying a mammalian antibody response to epstein-barr virus membrane antigen |
| 04/14/1993 | EP0536317A1 Mast cell growth factor |
| 04/14/1993 | EP0536299A1 Surface complexed lymphotoxin |
| 04/14/1993 | EP0536275A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 04/14/1993 | EP0536245A1 Novel, protracted insulin analogues |
| 04/14/1993 | EP0536234A1 Vectors containing hiv packaging sequences, packaging defective hiv vectors, and uses thereof |
| 04/14/1993 | EP0536215A1 Neurofibromatosis gene |
| 04/14/1993 | EP0536213A1 Sexe determining gene |
| 04/14/1993 | EP0536186A1 Bone and cartilage inductive proteins |
| 04/14/1993 | EP0536177A1 Thrombin inhibitors based on the amino acid sequence of hirudin |
| 04/14/1993 | EP0380546B1 Polypeptides with type iv collagen activity |
| 04/14/1993 | EP0313651B1 Synthetic peptides for diagnosis and prevention of influenza virus infection and their use |
| 04/14/1993 | CN1070946A Composition for introducing nucleic acid complexes into higher eucaryotic cells |
| 04/13/1993 | US5202451 Anchimeric radiometal chelating compounds |
| 04/13/1993 | US5202430 DNA sequence, encoding, polypeptide, vaccine |
| 04/13/1993 | US5202429 DNA molecules having human BCL-2 gene sequences |
| 04/13/1993 | US5202428 DNA encoding neurotropic growth factor |
| 04/13/1993 | US5202424 Mesangial cell-derived receptors for advanced glycosylation endproducts and uses thereof |
| 04/13/1993 | US5202422 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins and method of their use |
| 04/13/1993 | US5202421 Anticoagulant substance obtained from urine and process for the preparation thereof |
| 04/13/1993 | US5202420 Pure genetically engineered peptides which inhibit growth of escherichia |
| 04/13/1993 | US5202419 Anticoagulative protein pp4-x |
| 04/13/1993 | US5202417 60-amino-acid polypeptide |
| 04/13/1993 | US5202415 Having 29 first amino acids of B chain of human insulin linked to 21 amino acids of A chain by specified amino acids |
| 04/13/1993 | US5202311 Fibroblast growth factor stabilized with salt of sucrose octasulfate |
| 04/13/1993 | US5202259 Expression of human immunodeficiency virus (HIV) reverse transcriptase |
| 04/13/1993 | US5202257 Pure DNA which is capable of hybridizing with receptor polynucleotides under mild conditions |
| 04/13/1993 | US5202256 DNA segment encoding mussel protein linked to promoter and transcription initiation signals |
| 04/13/1993 | US5202247 Hybrid protein containing polypeptide fused to substrate binding region of amino acid sequence |
| 04/13/1993 | US5202239 Expression of recombinant polypeptides with improved purification |
| 04/13/1993 | US5202236 Marine animal extracts |
| 04/13/1993 | US5202234 Myocardial infarction immunoassay |
| 04/13/1993 | US5202232 Immunological testing |
| 04/13/1993 | US5202117 Method of treating thrombi with g-csf |
| 04/13/1993 | US5202113 Plaque-inhibiting protein from bacteroides loeschei and methods for using the same |
| 04/13/1993 | US5202006 Using barbituric acid buffer |
| 04/13/1993 | CA1316133C Method of using bar1 for secreting foreign proteins |
| 04/13/1993 | CA1316132C Cdna and gene for human angiogenin (angiogenesis factor) and method of expression |
| 04/12/1993 | CA2080258A1 Process for the purification of streptolysin o, intact streptolysin o obtainable by this process and its use |
| 04/11/1993 | CA2080309A1 Mutations in ryanodine receptor causative of human malignant hyperthermia |
| 04/10/1993 | WO1993007487A1 Method of detecting mesitylene-resistant staphylococcus aureus, novel peptide, and dna coding for same |
| 04/10/1993 | WO1993006840A1 Medicine for preventing and treating bleeding tendency |
| 04/10/1993 | CA2098008A1 Agent for preventing or treating hemorrhage tendency |
| 04/10/1993 | CA2097912A1 Method of detecting methicillin-resistant staphylococcus aureus, novel peptides, and dnas encoding the same |
| 04/08/1993 | DE4133189A1 Natural antiinflammatory agents - comprises fluid secreted after inducing cutaneous allergic reaction |
| 04/08/1993 | CA2079439A1 Non-a, non-b peptides |
| 04/07/1993 | EP0535899A1 Injectable extended release formulations and methods |
| 04/07/1993 | EP0535804A1 Peptide compounds |
| 04/07/1993 | EP0535337A2 Cell growth inhibiting activities of heparin binding neurite-outgrowth promoting factor |
| 04/07/1993 | EP0535336A2 MK protein as cell growth inhibitor |
| 04/07/1993 | EP0535216A1 Dna encoding mammalian phosphodiesterases |
| 04/07/1993 | EP0535161A1 Expression vectors containing the hiv nef gene to enhance replication efficiency |
| 04/07/1993 | EP0535155A1 Libraries of modified peptides with protease resistance |
| 04/07/1993 | EP0535154A1 Heterohybridomas producing human monoclonal antibodies to hiv-1 |
| 04/07/1993 | EP0535151A1 Peptide library and screening systems |
| 04/07/1993 | EP0535148A1 Stimulation of bone marrow stromal and progenitor cells |
| 04/07/1993 | EP0535119A1 A novel vector to produce biologically important peptides |
| 04/07/1993 | EP0535092A1 Protease nexin-i variants |
| 04/07/1993 | EP0535088A1 Chimeric toxins with improved inter-domain geometry |
| 04/07/1993 | EP0535060A1 Antifungal polypeptide, process for producing it. |
| 04/07/1993 | EP0535053A1 RECOMBINANT 47 AND 31kD COCOA PROTEINS AND PRECURSOR |
| 04/07/1993 | EP0535052A1 Oligosaccharide oxazolines, oligosaccharide conjugates and methods of preparation thereof |
| 04/07/1993 | EP0535039A1 Novel bacteriocin from a strain of lactococcus lactis subsp. cremoris |
| 04/07/1993 | EP0535038A1 Mammalian adipogenic factors |
| 04/07/1993 | EP0535021A1 Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome |
| 04/07/1993 | EP0535007A1 A MONOCLONAL ANTIBODY AGAINST THE GAG PROTEIN PRECURSOR p55 OF HUMAN IMMUNODEFICIENCY VIRUS. |
| 04/07/1993 | EP0534978A1 Interleukin-1 antagonist and uses thereof |
| 04/07/1993 | EP0534963A1 Immunoassay to detect pseudocercosporella antigen in cereal plants |
| 04/07/1993 | EP0491849A4 A method for the purification of transforming growth factor (tgf-) |
| 04/07/1993 | EP0366728B1 Polypeptides with fibronectin activity |
| 04/07/1993 | EP0233936B1 Synthetic polypeptides for detecting mycobacterial infections |
| 04/07/1993 | EP0215110B1 Production of human somatomedin c |
| 04/07/1993 | CN1070685A Multiple hepatitis B virus surface proteins which form particles |
| 04/06/1993 | US5200510 Utilizing a preferential binding peptide bound to an insoluble matrix; elution; collection |
| 04/06/1993 | US5200509 Human somatomedin carrier protein subunits and process for producing them; recombinant DNA molecules, hosts, processes and human somatomedin carrier protein-like polypeptides |
| 04/06/1993 | US5200505 R106 compounds |
| 04/06/1993 | US5200471 Immobilization on an azlactone-functional polymeric support in the presence of a polyanionic salt buffer and quenching |
| 04/06/1993 | US5200397 Administering an oligopeptides anticoagulants or wound healing agents |
| 04/06/1993 | US5200393 A lipid excipient of mono-oleoyl phosphatidylethanolamine (a lysophospholipid), a salt solution and a water soluble protein e.g. insulin |
| 04/06/1993 | US5200344 Diagnostic testing for campylobacter jejuni or campylobacter coli infections using novel antigens |
| 04/06/1993 | US5200341 Altered gene and E. coli strains and methods useful in enhanced accumulation of proteins |
| 04/06/1993 | US5200339 Brain-derived, calcium-activated proteolytic factor comprising a serine protease; Alzheimer's disease |
| 04/06/1993 | US5200327 Regulatory nucleotide sequence, including promoter and signal sequences, linked to sequence encoding heterologous protein |
| 04/06/1993 | US5200183 Recombinant bile salt activated lipases |
| 04/06/1993 | CA1315725C Lipid microemulsions for culture media |
| 04/06/1993 | CA1315675C Lactoferrin as a dietary ingredient promoting the growth of the gastointestinal tract |
| 04/02/1993 | CA2079541A1 Injectable extended release formulations and methods |
| 04/02/1993 | CA2076830A1 "curculin c" |
| 04/01/1993 | WO1993006488A1 Peptide based hepatitis c virus immunoassays |
| 04/01/1993 | WO1993006248A1 Detection method for c-raf-1 genes |
| 04/01/1993 | WO1993006247A1 Hepatitis c assay |
| 04/01/1993 | WO1993006238A1 cDNA ENCODING A DOPAMINE TRANSPORTER AND PROTEIN ENCODED THEREBY |
| 04/01/1993 | WO1993006231A1 Anti-human milk fat globule humanised antibodies |
| 04/01/1993 | WO1993006230A1 Annexin xi |
| 04/01/1993 | WO1993006229A1 CLONING OF cDNA ENCODING A FUNCTIONAL HUMAN INTERLEUKIN-8 RECEPTOR |
| 04/01/1993 | WO1993006228A1 A new form of liposaccharide binding protein (lbp) |
| 04/01/1993 | WO1993006219A1 Secondary-metabolite biosynthesis genes from actinomycetes, method of isolating them, and their use |